These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33318751)

  • 1. Patent Foramen Ovale Closure: State of the Art.
    Giblett JP; Williams LK; Kyranis S; Shapiro LM; Calvert PA
    Interv Cardiol; 2020 Apr; 15():e15. PubMed ID: 33318751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent Foramen Ovale Closure in 2019.
    Giblett JP; Abdul-Samad O; Shapiro LM; Rana BS; Calvert PA
    Interv Cardiol; 2019 Feb; 14(1):34-41. PubMed ID: 30858890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Data and Discussion - Who Should Undergo Patent Foramen Ovale Closure in 2014?
    Bhan A; Clapp B
    Interv Cardiol; 2014 Apr; 9(2):115-120. PubMed ID: 29588788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To close or not to close: contemporary indications for patent foramen ovale closure.
    Zier LS; Sievert H; Mahadevan VS
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1235-1244. PubMed ID: 27616622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent Foramen Ovale Percutaneous Closure: Evolution and Ongoing Challenges.
    Devos P; Guedeney P; Montalescot G;
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale closure for secondary prevention of cryptogenic stroke.
    Kolte D; Palacios IF
    Expert Rev Cardiovasc Ther; 2021 Mar; 19(3):211-220. PubMed ID: 33605829
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent foramen ovale: anatomy, outcomes, and closure.
    Calvert PA; Rana BS; Kydd AC; Shapiro LM
    Nat Rev Cardiol; 2011 Mar; 8(3):148-60. PubMed ID: 21283148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent pathology of the patent foramen ovale: a review of the literature.
    Cho KK; Khanna S; Lo P; Cheng D; Roy D
    Med J Aust; 2021 Jul; 215(2):89-93. PubMed ID: 34218432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.
    Kasner SE; Sondergaard L; Nakum M; Gomez Montero M; Hashim M; Landaas EJ
    J Med Econ; 2024; 27(1):337-343. PubMed ID: 38373018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
    Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
    Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on Patent Foramen Ovale (PFO) Closure.
    Voudris KV; Poulin MF; Kavinsky CJ
    Curr Cardiol Rep; 2024 Jul; 26(7):735-746. PubMed ID: 38913234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
    Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
    Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale--assessment and treatment.
    Irwin B; Ray S
    Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Patent Foramen Ovale Closure: Stroke and Beyond.
    Randhawa S; Mehta JL; Dhar G
    Curr Cardiol Rev; 2024; 20(3):77-86. PubMed ID: 38485682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure.
    Lantz M; Kostulas K; Settergren M; Sjöstrand C
    J Interv Cardiol; 2017 Jun; 30(3):242-248. PubMed ID: 28439982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of closure of patent foramen ovale in cryptogenic stroke: Current status.
    Abhishek BS; Bhambhani A
    Natl Med J India; 2017; 30(5):268-271. PubMed ID: 29916427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.